Product Images Simvastatin
View Photos of Packaging, Labels & Appearance
- Footnote for Table 3 - Footnote for Table 3
- Label - lbl713351906
- Figure 9 - simvastatin 10
- table2 - simvastatin 2
- Structure - simvastatin 3
- table 3 - simvastatin 4
- table 4 - simvastatin 5
- Figure 5 - simvastatin 6
- Figure 6 - simvastatin 7
- Figure 7 - simvastatin 8
- Figure 8 - simvastatin 9
- table 1 - table1
Product Label Images
The following 12 images provide visual information about the product associated with Simvastatin NDC 71335-1906 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Footnote for Table 3 - Footnote for Table 3
Results obtained from a chemical assay indicate potential inhibitors of CYP3A4 enzyme which include Ketoconazole, erythromycin, clarithromycin, HIV protease inhibitors, and nefazodone. The text also explains that simvastatin acid refers to the p-hydroxyacid of simvastatin, but the effect of grapefruit juice on simvastatin pharmacokinetics is not established. Grapefruit juice was used in different amounts in two studies along with single or multiple doses of simvastatin. The text also mentions that the results exclude those with propranolol.*
Label - lbl713351906
The text appears to be a medication label for Simvastatin, a drug used to lower cholesterol and triglycerides in the blood. It specifies that the tablet is pink and oval-shaped with the marking "B303;40" and contains 40mg of the drug. It provides instructions to store the medication at room temperature and to keep all drugs out of reach of children. There are also details about the manufacturer, expiration date, and NDC (National Drug Code).*
Figure 9 - simvastatin 10
table2 - simvastatin 2
This is a table showing Adverse Reactions reported by patients treated with Simvastatin compared to Placebo. The table lists the percentage of patients experiencing different types of disorders that are greater than placebo in 45 individuals. The disorders mentioned in the table include Edema/swelling, Abdominal pain, Atrial fibrillation, Constipation, Gastritis, Diabetes mellitus, Myalgia, Headache, Insomnia, Vertigo, Bronchitis, Sinusitis, Eczema, and Urinary tract infections.*
Structure - simvastatin 3
table 3 - simvastatin 4
table 4 - simvastatin 5
Figure 5 - simvastatin 6
Not available.*
Figure 6 - simvastatin 7
Figure 7 - simvastatin 8
Figure 8 - simvastatin 9
table 1 - table1
The given text seems to be a table of "Drug Interactions Associated with an Increased Risk of Myopathy/Rhabdomyolysis". It lists different drugs that are known to increase the risk of Myopathy when taken with simvastatin (a type of medication used to lower cholesterol levels in the blood). The table offers prescribing recommendations or advises to avoid exceeding the recommended dosage for each interacting agent. However, the last line appears to be scrambled and is not coherent.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
